CDMO for APIs & finished dosage forms

The New Development Centre

THE ABILITY TO HANDLE HIGH POTENT AND CONTROLLED DRUGS

THE WHOLE SUPPLY CHAIN. SIMPLIFIED

from early stage development to full scale manufacture

Meeting serialisation challenges

We're ahead of the game

Active Pharmaceutical Ingredients (API)

Say hello to Aesica at CPhI/ICSE, stand 4.1H10, to find out how Aesica – a Consort Medical...

With a counterfeit drug market now estimated at $200bn, many countries are putting serialisation...

CONSORT MEDICAL VIDEO

In collaboration with a key strategic customer, Aesica has brought to market readiness a product manufactured using the first semi-continuous...

Aesica is working with a leading Japanese pharmaceutical company to provide the active ingredient for an antiinflammatory formulation containing S...